Document is current

Article History

Received: 8 March 2022

Accepted: 20 July 2022

First Online: 30 July 2022

Declarations

:

: The study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki. The Dutch regulatory agency, registered at the US Office for Human Research Protections (IRB00002991), approved this study. All patients gave written informed consent to participate in the study, before inclusion. Authors are responsible for correctness of the statements provided in the manuscript. See also Authorship Statement.

: Patients signed informed consent regarding publishing their data.

: The following authors are members of the funding body ICC<i>:</i> GB<i>,</i> NKB<i>,</i> HHF<i>,</i> BO. HHF has served as a speaker for Janssen and Takeda. She has served as a consultant for Takeda, Galapagos and Ferring. She has received a research grant from Takeda. All outside the submitted work. BO has served as a speaker for Takeda, Galapagos, MSD. Grants: Pfizer, Takeda, Ferring. He has served as consultant/advisory board for Janssen, Pfizer, Takeda, Cablon. All outside the submitted work.NKB has served as a speaker for AbbVie and MSD. He has served as consultant and principal investigator for TEVA Pharma BV and Takeda. He has received a (unrestricted) research grant from Dr Falk, TEVA Pharma BV, MLDS and Takeda. All outside the submitted work.GB has served as a speaker for AbbVie and has served as a consultant for Takeda, Roche and Dr Falk, all not related to the submitted work. MMM, MLS, RJ and MBC declare that they have no ethical conflicts to disclose.